Загрузка...
Preexisting drug-resistance mutations reveal unique barriers to resistance for distinct antivirals
Clinical trials of direct-acting antiviral agents in patients chronically infected with hepatitis C virus (HCV) have demonstrated that viral resistance is detected rapidly during monotherapy. In patients, HCV does not exist as a single, genetically homogenous virus but rather as a population of vari...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
National Academy of Sciences
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3121856/ https://ncbi.nlm.nih.gov/pubmed/21646519 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1101515108 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|